Overcoming the hurdles
presented by inherited retinal disease
ATSENA THERAPEUTICS’ programs include cutting-edge gene therapies for leading forms of Leber congenital amaurosis and Usher syndrome. Our pipeline of proprietary assets is powered by adeno-associated virus (AAV) technology tailored to overcome the hurdles presented by inherited retinal disease.